VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
GSK Re-files Hepatitis B Drug Bepirovirsen for Marketing Approval in China
GSK Re-files Hepatitis B Drug Bepirovirsen for Marketing Approval in China
May 28, 2026 08:23 CST Updated 12:14
Share:
GSK
Pharmaceutical R&D Manufacturer